P. Kelly Marcom
1993–2024 年に発表
- 80
- 論文数
- 21,632
- 被引用数
- 67
- h 指数
- 80
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine57.9%
- Biochemistry, Genetics and Molecular Biology34.8%
- Computer Science1.4%
- Engineering1.4%
- Immunology and Microbiology1.2%
- Economics, Econometrics and Finance1%
- その他2.3%
トピック
- Breast Cancer Treatment Studies8.7%
- HER2/EGFR in Cancer Research5.8%
- Advanced Breast Cancer Therapies3.3%
- BRCA gene mutations in cancer3.3%
- Cancer Treatment and Pharmacology3.2%
- Cancer Genomics and Diagnostics3.1%
- その他72.6%
共著者
- Harold J. Burstein21
- Eric P. Winer20
- Antonio C. Wolff17
- Clifford A. Hudis15
- Steven J. Isakoff14
- William J. Gradishar14
- Hope S. Rugo13
- Ingrid A. Mayer13
- Kimberly Blackwell13
- Benjamin O. Anderson12
- Ian E. Krop12
- Lisa A. Carey12
- Lori J. Goldstein12
- Lori J. Pierce12
- Mary Lou Smith12
- Matthew J. Ellis12
- Elizabeth Reed11
- Sharon H. Giordano11
- William B. Farrar11
- Beryl McCormick10
- Chau T. Dang10
- George Somlo10
- Hatem Soliman10
- Andres Forero9
全論文
- Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
著者: William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Jairam Krishnamurthy, Janice A. Lyons, P. Kelly Marcom, Jennifer M. Matro, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2020 被引用: 1,618
- TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
著者: Nadine Tung, Mark E. Robson, Steffen Ventz, Cesar A. Santa‐Maria, Rita Nanda, P. Kelly Marcom, Payal D. Shah, Tarah J. Ballinger, Eddy S. Yang, Shaveta Vinayak, Michelle Melisko, Adam Brufsky, Michelle K. DeMeo, C. David Jenkins, Susan M. Domchek, Alan D. D’Andrea, Nancy U. Lin, Melissa E. Hughes, Lisa A. Carey, Nick Wagle, Gerburg M. Wulf, Ian E. Krop, Antonio C. Wolff, Eric P. Winer, Judy E. Garber - Journal of Clinical Oncology 2020 被引用: 500
- Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
著者: Sara M. Tolaney, Paolo Tarantino, Noah Graham, Nabihah Tayob, Laia Paré, Guillermo Villacampa, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew J. Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Romualdo Barroso‐Sousa, Patricia Villagrasa, Michelle K. DeMeo, Molly DiLullo, Jorge Gómez Tejeda Zañudo, Jakob Weiß, Nikhil Wagle, Ann H. Partridge, Adrienne G. Waks, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Aleix Prat, Eric P. Winer - The Lancet Oncology 2023 被引用: 165
- Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis
著者: Susana García‐Recio, Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual, Aguirre A. de Cubas, Youli Xia, Brooke Felsheim, Marni B. McClure, Andrei Rajkovic, Ezgi Karaesmen, Markia A. Smith, Cheng Fan, Paula I. González-Ericsson, Melinda E. Sanders, Chad J. Creighton, Jay Bowen, Kristen Leraas, Robyn Burns, Sara E. Coppens, Amy Wheless, Salma Rezk, Amy Garrett, Joel S. Parker, Kelly K. Foy, Hui Shen, Ben Ho Park, Ian E. Krop, Carey K. Anders, Julie M. Gastier‐Foster, Mothaffar F. Rimawi, Rita Nanda, Nancy U. Lin, Claudine Isaacs, P. Kelly Marcom, Anna Maria Storniolo, Fergus J. Couch, Uma Chandran, Michael A. Davis, Jonathan C. Silverstein, Alexander J. Ropelewski, Minetta C. Liu, Susan G. Hilsenbeck, Larry Norton, Andrea L. Richardson, W. Fraser Symmans, Antonio C. Wolff, Nancy E. Davidson, Lisa A. Carey, Adrian V. Lee, Justin M. Balko, Katherine A. Hoadley, Peter W. Laird, Elaine R. Mardis, Tari A. King, AURORA US Network, Aguirre A. de Cubas, Charles M. Perou - Nature Cancer 2022 被引用: 114
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
著者: Sara M. Tolaney, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew J. Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Beth Overmoyer, Ann H. Partridge, Hao Guo, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Eric P. Winer - New England Journal of Medicine 2015 被引用: 748
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
著者: Lisa A. Carey, Hope S. Rugo, P. Kelly Marcom, Erica L. Mayer, Francisco J. Esteva, X. Cynthia, Minetta C. Liu, Anna Maria Storniolo, Mothaffar F. Rimawi, Andres Forero‐Torres, Antonio C. Wolff, Timothy J. Hobday, Anastasia Ivanova, Wing-Keung Chiu, Madlyn Ferraro, Emily Burrows, Philip S. Bernard, Katherine A. Hoadley, Charles M. Perou, Eric P. Winer - Journal of Clinical Oncology 2012 被引用: 493
- NCCN Guidelines Insights: Breast Cancer, Version 1.2017
著者: William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony Elias, William B. Farrar, Andres Forero, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena S. Moran, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth Reed, Kilian Salerno, Lee S. Schwartzberg, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda L. Telli, John H. Ward, Dorothy A. Shead, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2017 被引用: 542
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031
著者: Matthew J. Ellis, Vera J. Suman, Jeremy Hoog, Lin Li, Jacqueline Snider, Aleix Prat, Joel S. Parker, Jingqin Luo, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary Unzeitig, Julie Margenthaler, Gildy V. Babiera, P. Kelly Marcom, Joseph M. Guenther, Mark A. Watson, Marilyn Leitch, Kelly K. Hunt, John A. Olson - Journal of Clinical Oncology 2011 被引用: 560
- Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set
著者: Elizabeth Hope Cain, Ashirbani Saha, Michael R. Harowicz, Jeffrey R. Marks, P. Kelly Marcom, Maciej A. Mazurowski - Breast Cancer Research and Treatment 2018 被引用: 198
- Whole-genome analysis informs breast cancer response to aromatase inhibition
著者: Matthew J. Ellis, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, John W. Wallis, Brian Andrew Van Tine, Jeremy Hoog, Reece Goiffon, Theodore C. Goldstein, Sam Ng, Lin Li, Robert J. Crowder, Jacqueline Snider, Karla V. Ballman, Jason D. Weber, Ken Chen, Daniel C. Koboldt, Cyriac Kandoth, William Schierding, Joshua F. McMichael, Christopher A. Miller, Charles Lu, Christopher Harris, Michael D. McLellan, Michael C. Wendl, Katherine DeSchryver, D. Craig Allred, Laura J. Esserman, Gary Unzeitig, Julie A. Margenthaler, Gildy V. Babiera, P. Kelly Marcom, J. Michael Guenther, Marilyn Leitch, Kelly K. Hunt, John A. Olson, Tao Yu, Christopher A. Maher, Lucinda Fulton, Robert S. Fulton, Michelle Harrison, Ben Oberkfell, Feiyu Du, Ryan Demeter, Tammi L. Vickery, Adnan Elhammali, Helen Piwnica‐Worms, Sandra McDonald, Mark A. Watson, David J. Dooling, David M. Ota, Li-Wei Chang, Ron Bose, Timothy J. Ley, David Piwnica‐Worms, Joshua M. Stuart, Richard K. Wilson, Elaine R. Mardis - Nature 2012 被引用: 1,035
- Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
著者: Carey K. Anders, David S. Hsu, Gloria Broadwater, Chaitanya R. Acharya, John A. Foekens, Yi Zhang, Yixin Wang, P. Kelly Marcom, Jeffrey R. Marks, Phillip G. Febbo, Joseph R. Nevins, Anil Potti, Kimberly Blackwell - Journal of Clinical Oncology 2008 被引用: 913
- Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
著者: William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony Elias, William B. Farrar, Andres Forero, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena S. Moran, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth Reed, Kilian Salerno, Lee S. Schwartzberg, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda L. Telli, John H. Ward, Rashmi Kumar, Dorothy A. Shead - Journal of the National Comprehensive Cancer Network 2018 被引用: 1,616
- Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer
著者: Tufia C. Haddad, Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy, Katelyn Santo, Erica L. Mayer, Meghan Karuturi, Aki Morikawa, P. Kelly Marcom, Claudine Isaacs, Sun Young Oh, Amy S. Clark, Ingrid A. Mayer, Khandan Keyomarsi, Timothy J. Hobday, Prema P. Peethambaram, Ciara C. O’Sullivan, Roberto A. Leon‐Ferre, Minetta C. Liu, James N. Ingle, Matthew P. Goetz - JAMA Oncology 2023 被引用: 52
- TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial)
著者: Nadine Tung, Banu Arun, Michele R. Hacker, Erin Hofstatter, Deborah Toppmeyer, Steven J. Isakoff, Virginia F. Borges, Robert D. Legare, Claudine Isaacs, Antonio C. Wolff, P. Kelly Marcom, Erica L. Mayer, Paulina Lange, Andrew J. Goss, C. David Jenkins, Ian E. Krop, Eric P. Winer, Stuart J. Schnitt, Judy E. Garber - Journal of Clinical Oncology 2020 被引用: 130
- Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
著者: Andrew J. Armstrong, Matthew S. Marengo, Sebastian Oltean, Gabor Kemeny, Rhonda L. Bitting, James Turnbull, Christina I. Herold, P. Kelly Marcom, Daniel J. George, Mariano A. García-Blanco - Molecular Cancer Research 2011 被引用: 650
- Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
著者: Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, Chau T. Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese M. Mulvey, Ron Bose, Douglas Weckstein, Antonio C. Wolff, Katherine E. Reeder‐Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Sayam Zuckerman, Lowell L. Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Audrey Merrill Garrett, P. Kelly Marcom, Kathy S. Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar F. Rimawi, Vandana G. Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero‐Torres, Minetta C. Liu, Kathryn J. Ruddy, Adrienne G. Waks, Michelle K. DeMeo, Harold J. Burstein, Ann H. Partridge, Patrizia Dell’Orto, Leila Russo, Emma Krause, Daniel Newhouse, Busem Binboğa Kurt, Elizabeth A. Mittendorf, Bryan P. Schneider, Aleix Prat, Eric P. Winer, Ian E. Krop, Sara M. Tolaney, Romualdo Barroso‐Sousa, Giuseppe Curigliano, Molly DiLullo, Winnie W. Hui, Christian Kirkup, Giuseppe Viale, Yue Zheng - Journal of Clinical Oncology 2024 被引用: 38
- Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort
著者: Rachel A. Greenup, Adam H. Buchanan, Wendy Lorizio, Keelia Rhoads, Salina Chan, Tracey P. Leedom, Robin H. King, Jane McLennan, Beth Crawford, P. Kelly Marcom, E. Shelley Hwang - Annals of Surgical Oncology 2013 被引用: 226
- Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
著者: Veerle Bossuyt, Elena Provenzano, W. Fraser Symmans, Judy C. Boughey, Charlotte E. Coles, Giuseppe Curigliano, J. Michael Dixon, Laura J. Esserman, Gerd Fastner, Thorsten Kuehn, Florentia Peintinger, Gϋnter von Minckwitz, Julia White, Wei Yang, Sunil Badve, Carsten Denkert, Gaëtan MacGrogan, Frédérique Penault‐Llorca, Giuseppe Viale, David Cameron, Helena Earl, Emilio Alba, Aňa Lluch, Joan Albanell, Keith D. Amos, Wojciech Biernat, Hervé Bonnefoi, Aman U. Buzdar, Paul Cane, Sarah E. Pinder, L. F. Carson, Diana Dickson-Witmer, Gyungyub Gong, Jimmy Green, Chih‐Yi Hsu, Ling‐Ming Tseng, Judith R. Kroep, A. Marilyn Leitch, Venetia Sarode, E. Mamounas, P. Kelly Marcom, Paolo Nucíforo, Soonmyung Paik, Vicente Peg, David Peston, Jean‐Yves Pierga, Miguel Quintela-Fandiño, Roberto Salgado, William M. Sikov, Jeremy Thomas, Gary Unzeitig, Jelle Wesseling - Annals of Oncology 2015 被引用: 238
- Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
著者: Erika J. Crosby, William R. Gwin, Kimberly Blackwell, P. Kelly Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, Terry Hyslop, Sungjin Kim, André Rogatko, Veronica Lubkov, Joshua C. Snyder, Takuya Osada, Amy Hobeika, Michael A. Morse, H. Kim Lyerly, Zachary C. Hartman - Clinical Cancer Research 2019 被引用: 80
- Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840
著者: Andrew D. Seidman, Donald A. Berry, Constance Cirrincione, Lyndsay N. Harris, Hyman B. Muss, P. Kelly Marcom, Grandella Gipson, Harold J. Burstein, Diana Lake, Charles L. Shapiro, Peter C. Ungaro, Larry Norton, Eric P. Winer, Clifford A. Hudis - Journal of Clinical Oncology 2008 被引用: 604
- Breast Cancer, Version 3.2018
著者: Matthew P. Goetz, William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, William B. Farrar, Sharon H. Giordano, Lori J. Goldstein, Steven J. Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth M. O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth Reed, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Melinda L. Telli, John H. Ward, Jessica Young, Dorothy A. Shead, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2019 被引用: 199
- Randomized Trial of Telegenetics vs. In‐Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance
著者: Adam H. Buchanan, Santanu Datta, Celette Sugg Skinner, Gail P. Hollowell, Henry F. Beresford, Thomas Freeland, Benjamin H. Rogers, John Boling, P. Kelly Marcom, Martha Adams - Journal of Genetic Counseling 2015 被引用: 184
- The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer
著者: Cynthia X. Ma, Jingqin Luo, Rachel A. Freedman, Timothy J. Pluard, Julie R. Nangia, Janice Lu, Frances Valdez-Albini, Melody Cobleigh, Jason M. Jones, Nancy U. Lin, Eric P. Winer, P. Kelly Marcom, Shana Thomas, Jill Anderson, Brittney Haas, Leslie Bucheit, Richard Bryce, Alshad S. Lalani, Lisa A. Carey, Matthew P. Goetz, Feng Gao, Gretchen Kimmick, Mark D. Pegram, Matthew J. Ellis, Ron Bose - Clinical Cancer Research 2022 被引用: 57
- Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
著者: Sara M. Tolaney, Hao Guo, Sònia Pernas, William T. Barry, Deborah Dillon, Lauren L. Ritterhouse, Bryan P. Schneider, Fei Shen, Kit Fuhrman, Michele Baltay, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Mathew J. Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Beth Overmoyer, Ann H. Partridge, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Eric P. Winer - Journal of Clinical Oncology 2019 被引用: 280
